Orchid Pharma Reports Q-2 & Half Year Results for 2025 with 20.99% EPS Growth

Orchid Pharma Ltd. has reported its unaudited limited reviewed financial results for the quarter and half year ended on September 30, 2025. The company's net sales stood at INR 19,352.42 lakhs, INR 36,645.30 lakhs, and INR 57,435.50 lakhs for the quarter, half year, and year ended September 30, 2025, respectively. The company's profit before tax was INR 2,006.54 lakhs, INR 4,205.98 lakhs, and INR 8,636.06 lakhs for the same periods. The earnings per share (EPS) for the year ended September 30, 2025, was INR 20.99. The company's total assets stood at INR 80,741.73 lakhs and INR 1,68,791.47 lakhs for the half year and year ended September 30, 2025, respectively.